{"id":"W2917035693","doi":"10.1001/jamanetworkopen.2019.0035","title":"Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Spark Therapeutics; Genentech; Regeneron Pharmaceuticals; AstraZeneca; Laura and John Arnold Foundation; Kaiser Permanente; GlaxoSmithKline; Blue Shield of California Foundation; Sanofi; National Pharmaceutical Council; Mallinckrodt Pharmaceuticals; Alnylam Pharmaceuticals; California Health Care Foundation","keywords":"Medicine; Oncology; Lymphoma; Survival analysis; Internal medicine; Cost effectiveness; Quality-adjusted life year; Cohort","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01421773,0.0009234669,0.001417351,0.001214927,0.0002363665,0.002033401,0.0008870199,0.001317896,0.002676264],"category_scores_gemma":[0.03788918,0.0004043994,0.004232657,0.00103465,0.0008517535,0.002016314,0.001185267,0.001996221,0.0001276814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005366459,"about_ca_system_score_gemma":0.001773586,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0035261,"about_ca_topic_score_gemma":0.002721456,"domain_scores_codex":[0.9938068,0.004790354,0.0002746855,0.0003507309,0.0004252508,0.0003521698],"domain_scores_gemma":[0.9853576,0.01140872,0.0021706,0.000249424,0.0003139581,0.000499679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.1950433,0.004021118,0.1014533,0.004193809,0.01638385,0.0005547203,0.0003257096,0.5541105,0.001635272,0.01151189,0.001643387,0.1091232],"study_design_scores_gemma":[0.02114993,0.0535058,0.09905425,0.002847207,0.02181957,0.001110609,0.0007607116,0.7714258,0.003448585,0.02020248,0.004359885,0.0003151413],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776378,0.0124652,0.004517049,0.001200712,0.0000869373,0.0006648677,0.001210121,0.00003282856,0.002184484],"genre_scores_gemma":[0.9969226,0.001041697,0.001087943,0.00009859828,0.00001655004,0.0001690102,0.0004406254,0.000005046202,0.0002179153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01421773,"threshold_uncertainty_score":0.07519138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04220927045853014,"score_gpt":0.3345751585168903,"score_spread":0.2923658880583602,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}